sj-docx-1-smo-10.1177_20503121231225874 – Supplemental material for Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with Phe508del mutation: Evidence from randomized controlled trials

Abstract

Supplemental material, sj-docx-1-smo-10.1177_20503121231225874 for Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with Phe508del mutation: Evidence from randomized controlled trials by Rong He, Fei Lin, Zehui Deng and Bin Yu in SAGE Open Medicine</p